Head and neck cancer(HNC) is a rare and heterogeneous disease with disparities in incidence and survival rates between Europe and the United States.73,74Based on the EUROCARE-5 population-based study, the incidence rate oforal cavitycarcinoma(OCC),oropharyngeal carcinoma(OPC), andlarynx carcino...
Head and Neck NeoplasmsNeoplasm Recurrence, LocalCisplatinCarboplatinAntineoplastic Combined Chemotherapy ProtocolsPrognosisCombined Modality TherapyPalliative CareSurvival RatePlatinum-based chemotherapy has been used to treat head and neck cancer for approximately 15 years. For patients with recurrent disease, ...
Survival and data-driven phenotypes in head and neck cancer Anni Heinolainen ,Bruce Nguyen &Miika Koskinen Article 05 February 2025|Open Access Integrative analysis of 5-methylcytosine associated signature in papillary thyroid cancer Ying Ding
Response rate to anti-CD276 based immunotherapy remains suboptimal in patients with cancer. Here, in a chemically-induced murine model of head and neck squamous cell carcinoma, the authors show that expression of ITGB6 in tumor cells promotes resistance to anti-CD276 therapy, associated with accum...
Despite recent advances in the diagnosis and treatment of head and neck cancer, there has been little evidence of improvement in survival rates over the last few dec- ades [9]. Independent of the numerous reports on the epidemiology and molecular characteristics of HNSCCs in Ghana, there is a...
Head and neck cancer (HNC) is an aggressive malignancy with significant effects on the innervation. Not only is it at the top of the cancer spectrum with a dismal prognosis, but it also imposes considerable stress on patients and society owing to frequen
Head & Neck Cancers The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on ...
The tracking of these biomarkers is an important part for the identification of individuals in the early stages of head and neck cancer for its diagnostic and prognostic relevance reflecting in high survival rates, better quality of life and less cost to the healthcare system. Therefore, assuming...
Molecular Cytogenetics (2019) 12:33 https://doi.org/10.1186/s13039-019-0447-z REVIEW Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids – the state of art Ilda Patrícia Ribeiro1,2, Joana Barbosa de Melo1,2 and Isabel Marques Carreira1,2* Open Access ...
The study claimed that human papillomavirus (HPV) positive people who have neck and head cancer are likely to have better survival rates than HPV-negative patients. The study found that HPV positive patients have 85% survival rate while HPV-negative people have 35% only....